Subtopic Deep Dive

Circulating Circular RNAs in Disease
Research Guide

What is Circulating Circular RNAs in Disease?

Circulating circular RNAs are stable circRNAs detected in blood plasma and exosomes serving as non-invasive biomarkers for diseases including cancer and neurological disorders.

Research identifies circRNAs enriched in exosomes for their resistance to RNase degradation, enabling liquid biopsy applications (Yan Li et al., 2015, 2300 citations). Studies correlate plasma circRNA levels with disease progression in hepatocellular carcinoma and gastric cancer (Dan Han et al., 2017, 1330 citations; Xing Zhang et al., 2019, 888 citations). Over 10 key papers since 2015 explore their biogenesis and diagnostic potential (Zhongrong Zhang et al., 2018, 806 citations).

Curated Papers

Key Challenges

Why It Matters

Circulating circRNAs enable early cancer detection via blood tests, as shown in exosome-enriched profiles for diagnosis (Yan Li et al., 2015). They support monitoring therapeutic responses in hepatocellular carcinoma through miRNA sponging mechanisms (Dan Han et al., 2017). In colorectal metastasis, serum circNSUN2 levels predict progression, facilitating non-invasive tracking (Rixin Chen et al., 2019). Applications extend to cardiovascular and neurological diseases via extracellular vesicle delivery (Killian P. O’Brien et al., 2020).

Key Research Challenges

Detection Sensitivity

Low circRNA abundance in plasma requires ultrasensitive assays beyond qPCR. RNase-free extraction from exosomes remains inconsistent (Yan Li et al., 2015). Standardization across cohorts is needed for reproducibility.

Specificity to Diseases

CircRNAs like circNRIP1 appear in multiple cancers, complicating disease-specific biomarkers (Xing Zhang et al., 2019). Confounding factors from normal circulation hinder validation (Yangxia Wang et al., 2019). Larger clinical trials are essential.

Biogenesis Mechanisms

m6A modifications drive cytoplasmic export of circNSUN2, but pathways in exosomes are unclear (Rixin Chen et al., 2019). Export regulation via extracellular vesicles varies by cell type (Killian P. O’Brien et al., 2020). Functional impacts need elucidation.

Essential Papers

Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis

Yan Li, Qiupeng Zheng, Chunyang Bao et al. · 2015 · Cell Research · 2.3K citations

RNA delivery by extracellular vesicles in mammalian cells and its applications

Killian P. O’Brien, Koen Breyne, Stefano Ughetto et al. · 2020 · Nature Reviews Molecular Cell Biology · 1.7K citations

Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression

Dan Han, Jiangxue Li, Huamin Wang et al. · 2017 · Hepatology · 1.3K citations

Noncoding RNAs play important roles in cancer biology, providing potential targets for cancer intervention. As a new class of endogenous noncoding RNAs, circular RNAs (circRNAs) have been recently ...

Exosomes: key players in cancer and potential therapeutic strategy

Jie Dai, Yangzhou Su, Suye Zhong et al. · 2020 · Signal Transduction and Targeted Therapy · 1.1K citations

Abstract Exosomes are extracellular vesicles secreted by most eukaryotic cells and participate in intercellular communication. The components of exosomes, including proteins, DNA, mRNA, microRNA, l...

Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway

Xing Zhang, Sen Wang, Haixiao Wang et al. · 2019 · Molecular Cancer · 888 citations

Extracellular vesicles as tools and targets in therapy for diseases

Mudasir A. Kumar, Sadaf Khursheed Baba, Hana Q. Sadida et al. · 2024 · Signal Transduction and Targeted Therapy · 859 citations

Abstract Extracellular vesicles (EVs) are nano-sized, membranous structures secreted into the extracellular space. They exhibit diverse sizes, contents, and surface markers and are ubiquitously rel...

N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis

Rixin Chen, Xin Chen, Liangping Xia et al. · 2019 · Nature Communications · 823 citations

Abstract Circular RNAs (circRNAs) have been implicated in cancer progression through largely unknown mechanisms. Herein, we identify an N 6 -methyladenosine (m 6 A) modified circRNA, circNSUN2, fre...

Reading Guide

Foundational Papers

Start with Yan Li et al. (2015) for exosome enrichment proof and stability data (2300 citations), then Kartha and Subramanian (2014) for ceRNA context foundational to circRNA sponging.

Recent Advances

Study Yangxia Wang et al. (2019) for biogenesis review and Rixin Chen et al. (2019) for m6A-modified serum circNSUN2 in metastasis.

Core Methods

Exosome isolation via ultracentrifugation, RNase R digestion for linear RNA removal, qPCR/NGS quantification, and miRNA sponge validation via luciferase assays.

How PapersFlow Helps You Research Circulating Circular RNAs in Disease

Discover & Search

Research Agent uses searchPapers and exaSearch to query 'circulating circRNAs exosomes cancer biomarkers' retrieving Yan Li et al. (2015) as top hit with 2300 citations. CitationGraph maps connections to Dan Han et al. (2017) and findSimilarPapers expands to 50+ related works on plasma detection.

Analyze & Verify

Analysis Agent applies readPaperContent on Yan Li et al. (2015) to extract exosome enrichment data, then verifyResponse with CoVe checks biomarker stability claims against 10 papers. runPythonAnalysis processes citation counts and expression levels via pandas for statistical verification; GRADE assigns high evidence to diagnostic correlations.

Synthesize & Write

Synthesis Agent detects gaps in multi-disease specificity using contradiction flagging across Xing Zhang et al. (2019) and Rixin Chen et al. (2019). Writing Agent employs latexEditText for biomarker review sections, latexSyncCitations for 20 references, and latexCompile for publication-ready manuscript; exportMermaid visualizes circRNA-miRNA sponge networks.

Use Cases

"Statistical analysis of circRNA expression levels from plasma datasets in cancer papers."

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas plots of fold-changes from Yan Li et al., 2015 data) → matplotlib correlation graphs output.

"Write LaTeX review on exosomal circRNAs with citations and figures."

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (for Dan Han et al., 2017) → latexCompile + latexGenerateFigure → PDF manuscript.

"Find GitHub code for circRNA detection from exosome RNA-seq papers."

Research Agent → paperExtractUrls (from Yangxia Wang et al., 2019) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified pipelines output.

Automated Workflows

Deep Research workflow scans 50+ papers on circulating circRNAs, chaining searchPapers → citationGraph → structured biomarker report with GRADE scores. DeepScan applies 7-step analysis to Yan Li et al. (2015), verifying exosome stability via CoVe checkpoints. Theorizer generates hypotheses on m6A export mechanisms from Rixin Chen et al. (2019) interactions.

Try Doxa for Circulating Circular RNAs in Disease Research

Frequently Asked Questions

What defines circulating circular RNAs?

Circulating circular RNAs are covalently closed circRNAs found in blood exosomes and plasma, resistant to degradation for biomarker use (Yan Li et al., 2015).

What are main detection methods?

qPCR and RNA-seq target exosome-enriched circRNAs after RNase R treatment; nanoplasmonic assays enhance sensitivity (Yangxia Wang et al., 2019).

What are key papers?

Yan Li et al. (2015, 2300 citations) shows exosome stability; Dan Han et al. (2017, 1330 citations) links circMTO1 to HCC; Xing Zhang et al. (2019, 888 citations) details circNRIP1 in gastric cancer.

What open problems exist?

Disease-specific panels lack validation; biogenesis in pathological EVs needs clarification; longitudinal studies for monitoring are absent (Rixin Chen et al., 2019).